Natural Investments’s DexCom DXCM Stock Holding History

Natural Investments’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$689K	Buy	10,232 +3,248	+47%	+$216K	0.15%	124
2026 Q1	$438K	Buy	+6,984	New	+$486K	0.11%	175

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Natural Investments's DXCM Position: Q2 2026 in Review

Natural Investments increased its DexCom (DXCM) stake by 47% in Q2 2026, buying an estimated $216K and bringing the position to 10,232 shares worth $689K. The position accounts for 0.15% of the portfolio, ranked #124.

Natural Investments first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Natural Investments held 10,232 shares of DexCom worth $689K as of Q2 2026.
Natural Investments bought 3,248 DexCom shares in Q2 2026, an estimated $216K.
DexCom made up 0.15% of Natural Investments's portfolio in Q2 2026, its #124 holding.
Natural Investments first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.